XVII CONGRESSO MINEIRO DE PNEUMOLOGIA E CIRURGIA TORÁCICA e VI CONGRESSO MINEIRO DE PNEUMOLOGIA PEDIÁTRICA
1º Dia - 10/10/25
2º Dia - 10/11/25
3º Dia - 10/9/25

O Eosinófilo na Asma - Onde Estamos? Voltar

Ricardo Gassman Figueiredo

Mesa Redonda - Asma: Diagnóstico e Abordagem Clínica - Rodrigo Luis Barbosa Lima

Artigo Autor(es) Referência
Advancements in biologic therapy in eosinophilic asthma. Patadia Rini, Casale Thomas B, Fowler John, Patel Shiven, Cardet Juan Carlos Expert opinion on biological therapy. 2024 Apr; 24(Apr):251-261. doi: 10.1080/14712598.2024.2342527. pii: .
Anti-interleukin-5 in the Management of Eosinophilic Asthma: A Review of Effectiveness, Safety, and Budgetary Impact From the Perspective of the Brazilian Health System. de Freitas Nakata Kelli Carneiro, Marques Luisa Daige, de Oliveira Helder Cássio, Magalhães Graciane Catarina Batista, de Oliveira Ruberlei Godinho, Botelho Clóvis Value in health regional issues. 2021 Sep; 26(Sep):169-181. doi: 10.1016/j.vhri.2021.06.010. pii: S2212-1099(21)00101-1.
Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. Nopsopon Tanawin, Lassiter Grace, Chen Ming-Li, Alexander G Caleb, Keet Corinne, Hong Hwanhee, Akenroye Ayobami The Journal of allergy and clinical immunology. 2023 Mar; 151(Mar):747-755. doi: 10.1016/j.jaci.2022.11.021. pii: S0091-6749(22)02498-8.
Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment. Boyce Joshua A, Eisenbarth Stephanie C The Journal of clinical investigation. 2024 Jun; 134(Jun):doi: 10.1172/JCI182410. pii: e182410.
Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review. Dighriri Ibrahim M, Alnughaythir Anas I, Albesisi Amna A, Alhuwaimel Danya I, Alotaibi Alanoud S, Alghowaidi Laila A, Almalki Fatimah H, Al-Bukhari Jasmine N, Alshammari Tahani R, Alwathnani Fahad H, Alghamdi Abdulmohsen A, Alghamdi Ali A, Alshehri Safar D, Mahnashi Nora Y, Abu Jamilah Hassan A Cureus. 2023 Dec; 15(Dec):e49781. doi: 10.7759/cureus.49781. pii: e49781.
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment. D'Aiuto Valentina, Mormile Ilaria, Granata Francescopaolo, Romano Antonio, Della Casa Francesca, Mignogna Gabriele, de Paulis Amato, Rossi Francesca Wanda International journal of molecular sciences. 2025 Feb; 26(Feb):doi: 10.3390/ijms26041729. pii: 1729.
Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons. Hussain Musaddique, Liu Gang Cells. 2024 Feb; 13(Feb):doi: 10.3390/cells13050384. pii: 384.
Eosinophils in asthma phenotypes: perpetrators or guilty by association? Lommatzsch Marek, Buhl Roland, Bergmann Karl-Christian, Brusselle Guy G, Canonica G Walter, Jackson David J, Heaney Liam G, Nair Parameswaran, Virchow J Christian The Lancet. Respiratory medicine. 2025 Jul; doi: 10.1016/S2213-2600(25)00174-2. pii: S2213-2600(25)00174-2.
Monitoring eosinophils to guide therapy with biologics in asthma: does the compartment matter? Koenderman Leo, Hassani Marwan, Mukherjee Manali, Nair Parameswaran Allergy. 2021 04; 76(04):1294-1297. doi: 10.1111/all.14700. pii: .
Regulation of Eosinophilia in Asthma-New Therapeutic Approaches for Asthma Treatment. Cusack Ruth P, Whetstone Christiane E, Xie Yanqing, Ranjbar Maral, Gauvreau Gail M Cells. 2021 Apr; 10(Apr):doi: 10.3390/cells10040817. pii: 817.
Tezepelumab in patients with allergic and eosinophilic asthma. Caminati Marco, Buhl Roland, Corren Jonathan, Hanania Nicola A, Kim Harold, Korn Stephanie, Lommatzsch Marek, Martin Neil, Matucci Andrea, Nasser Shuaib M, Pavord Ian D, Domingo Christian Allergy. 2024 May; 79(May):1134-1145. doi: 10.1111/all.15986. pii: .
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial. Ramakrishnan Sanjay, Russell Richard E K, Mahmood Hafiz R, Krassowska Karolina, Melhorn James, Mwasuku Christine, Pavord Ian D, Bermejo-Sanchez Laura, Howell Imran, Mahdi Mahdi, Peterson Stefan, Bengtsson Thomas, Bafadhel Mona The Lancet. Respiratory medicine. 2024 Nov; doi: 10.1016/S2213-2600(24)00299-6. pii: S2213-2600(24)00299-6.
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy. Bakakos Agamemnon, Rovina Nikoleta, Bakakos Petros International journal of molecular sciences. 2021 Apr; 22(Apr):doi: 10.3390/ijms22083969. pii: 3969.
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype. Jackson David J, Wechsler Michael E, Jackson Daniel J, Bernstein David, Korn Stephanie, Pfeffer Paul E, Chen Ruchong, Saito Junpei, de Luíz Martinez Gustavo, Dymek Lucyna, Jacques Loretta, Bird Nicholas, Schalkwijk Stein, Smith Douglas, Howarth Peter, Pavord Ian D, , , The New England journal of medicine. 2024 Dec; 391(Dec):2337-2349. doi: 10.1056/NEJMoa2406673. pii: .
Nenhuma revista foi definida para este congresso.